NRC-IRAP Contributes to the Development of Three Rivers SmartGuidewire™ Medical Devices
TORONTO, ON, February 19, 2016 - The National Research Council of Canada (NRC) provides support to Three Rivers for the development of their SmartGuidewire™ medical devices with the Industrial Research Assistance Program (IRAP).
Canada’s innovation assistance IRAP program for Canadian small and medium enterprises (SME) brings together a diverse set of assets to accelerate their growth. Through a network of organizations, services and programs, NRC-IRAP gives access to technological advisors, potential business partners and R&D financial assistance. The contribution program offers solutions designed to fit each company’s objectives.
“SmartGuidewire™ is a medical device solution that has high value for patients, cardiologists, hospitals, private health insurance companies and public healthcare systems,” states the National Research Council of Canada.
Three Rivers’ medical solutions provide innovative Canadian technology enabling more effective diagnosis and treatment of heart valve diseases along with improving patient’s quality of life.
“SmartGuidewire™ is a solution addressing major growing clinical problems with heart valve diseases, leading to sub-optimal care, adverse patient outcomes and increased healthcare costs. This project with NRC-IRAP allows us to further accelerate the development and launch of our SmartGuidewire™,” says Eric Caron, CEO of Three Rivers.
The NRC is the Government of Canada's premier research and technology organization.
About Three Rivers:
The company was founded in 2013 to develop and commercialize multi-sensor medical devices for interventional cardiologists. Three Rivers’ innovative medical devices provide real-time critical data for heart diagnosis and therapy to improve patient outcomes while reducing healthcare costs with heart diseases.